UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improvement of Overall and Failure-Free Survival in Stage IV Follicular Lymphoma: 25 Years of Treatment Experience at The University of Texas M.D. Anderson Cancer Center

Journal of clinical oncology, 2006-04, Vol.24 (10), p.1582-1589

2006

Volltextzugriff (PDF)

Impact of High-Dose Chemotherapy on Peripheral T-Cell Lymphomas

Journal of clinical oncology, 2001-09, Vol.19 (17), p.3766-3770

2001

Volltextzugriff (PDF)

Phase II Study of Denileukin Diftitox for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2004-10, Vol.22 (20), p.4095-4102

2004

Volltextzugriff (PDF)

Long-Term Follow-Up of a Prospective Study of Combined Modality Therapy for Stage I–II Indolent Non-Hodgkin’s Lymphoma

Journal of clinical oncology, 2003-06, Vol.21 (11), p.2115-2122

2003

Volltextzugriff (PDF)

Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia

Cancer, 2006-04, Vol.106 (7), p.1569-1580

2006

Volltextzugriff (PDF)

Phase II study of oxaliplatin in patients with recurrent or refractory non‐Hodgkin lymphoma

Cancer, 2005-08, Vol.104 (4), p.781-787

2005

Volltextzugriff (PDF)

NOVP chemotherapy for Hodgkin's disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, y, 18, and 21

Cancer research (Chicago, Ill.), 2003, Vol.63 (1), p.44-51

2003

Volltextzugriff (PDF)

European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte‐predominant Hodgkin disease

Cancer, 2002-03, Vol.94 (6), p.1731-1738

2002

Volltextzugriff (PDF)

Thalidomide for patients with recurrent lymphoma

Cancer, 2004-03, Vol.100 (6), p.1186-1189

2004

Volltextzugriff (PDF)

Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen

Cancer, 2005-07, Vol.104 (2), p.345-353

2005

Volltextzugriff (PDF)

An elevated serum beta‐2‐microglobulin level is an adverse prognostic factor for overall survival in patients with early‐stage Hodgkin disease

Cancer, 2002-12, Vol.95 (12), p.2534-2538

2002

Volltextzugriff (PDF)

Analysis of in-field control and late toxicity for adults with early-stage hodgkin’s disease treated with chemotherapy followed by radiotherapy

International journal of radiation oncology, biology, physics, 2003, Vol.55 (1), p.36-43

2003

Volltextzugriff (PDF)

Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes

Oncology reports, 2003-09, Vol.10 (5), p.1513

2003

Volltextzugriff (PDF)

Subdiaphragmatic stage I & II Hodgkin’s disease: long-term follow-up and prognostic factors

International journal of radiation oncology, biology, physics, 1998-07, Vol.41 (5), p.1047-1056

1998

Volltextzugriff (PDF)

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue

Cancer chemotherapy and pharmacology, 2002-05, Vol.49, p.S13-S20

HAGEMEISTER, Fredrick B

2002

Volltextzugriff (PDF)

Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination

Investigational new drugs, 1999-05, Vol.17 (2), p.187-192

1999

Volltextzugriff (PDF)

Frequent nonrandom chromosome abnormalities in 27 patients with untreated large cell lymphoma and immunoblastic lymphoma

Cancer research (Chicago, Ill.), 1988-10, Vol.48 (19), p.5557-5564

1988

Volltextzugriff (PDF)

Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma

Seminars in oncology, 2000-12, Vol.27 (6), p.37-41

2000

Volltextzugriff (PDF)

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

Journal of clinical oncology, 1992-05, Vol.10 (5), p.790-794

1992

Volltextzugriff (PDF)

Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease

Journal of clinical oncology, 1997-12, Vol.15 (12), p.3488-3495

1997

Volltextzugriff (PDF)

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma

Journal of clinical oncology, 1994-03, Vol.12 (3), p.575-579

1994

Volltextzugriff (PDF)

Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model

Journal of clinical oncology, 1991-05, Vol.9 (5), p.762-769

1991

Volltextzugriff (PDF)

Radiotherapy during pregnancy for clinical stages IA–IIA Hodgkin's disease

International journal of radiation oncology, biology, physics, 1992, Vol.23 (2), p.407-412

1992

Volltextzugriff (PDF)

Significance of tumor size and radiation dose to local control in Stage I–III diffuse large cell lymphoma treated with CHOP-Bleo and radiation

International journal of radiation oncology, biology, physics, 1995, Vol.31 (1), p.3-11

1995

Volltextzugriff (PDF)

No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule

Journal of clinical oncology, 1996-02, Vol.14 (2), p.543-548

1996

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

Humans
(37)
Life Sciences & Biomedicine
(37)
Medical Sciences
(37)
Science & Technology
(37)
Middle Aged
(28)
Male
(27)
Adult
(26)
Female
(26)
Aged
(23)
Pharmacology. Drug Treatments
(20)
Antineoplastic Agents
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(18)
Hematologic And Hematopoietic Diseases
(15)
Chemotherapy
(14)
Combined Modality Therapy
(14)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(14)
Treatment Outcome
(13)
Lymphoma, Non-Hodgkin - Drug Therapy
(11)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Improvement of Overall and Failure-Free Survival in Stage IV Follicular Lymphoma: 25 Years of Treatment Experience at The University of Texas M.D. Anderson Cancer Center

Impact of High-Dose Chemotherapy on Peripheral T-Cell Lymphomas

Phase II Study of Denileukin Diftitox for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Long-Term Follow-Up of a Prospective Study of Combined Modality Therapy for Stage I–II Indolent Non-Hodgkin’s Lymphoma

Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia

Phase II study of oxaliplatin in patients with recurrent or refractory non‐Hodgkin lymphoma

NOVP chemotherapy for Hodgkin's disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, y, 18, and 21

European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte‐predominant Hodgkin disease

Thalidomide for patients with recurrent lymphoma

Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen

An elevated serum beta‐2‐microglobulin level is an adverse prognostic factor for overall survival in patients with early‐stage Hodgkin disease

Analysis of in-field control and late toxicity for adults with early-stage hodgkin’s disease treated with chemotherapy followed by radiotherapy

Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes

Subdiaphragmatic stage I & II Hodgkin’s disease: long-term follow-up and prognostic factors

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue

Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination

Frequent nonrandom chromosome abnormalities in 27 patients with untreated large cell lymphoma and immunoblastic lymphoma

Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma

Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model

Radiotherapy during pregnancy for clinical stages IA–IIA Hodgkin's disease

Significance of tumor size and radiation dose to local control in Stage I–III diffuse large cell lymphoma treated with CHOP-Bleo and radiation

No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule

Aktive Filter

Suchergebnisse filtern